Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024

Rhea-AI Summary

Edgewise Therapeutics, Inc. (EWTX) will present at the Leerink Partners Global Biopharma Conference on March 11, 2024. The presentation will be webcast live and accessible for replay. Users are advised to connect early for a smooth experience.

BOULDER, Colo.--(BUSINESS WIRE)-- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the Leerink Partners Global Biopharma Conference on Monday, March 11, 2024, at 12:00 pm ET.

The presentation will be webcast live; a link for the webcast can be found on the Edgewise events page and will be accessible for replay following the presentation. It is recommended that users connect to the webcast several minutes prior to the start to ensure a timely connection.

About Edgewise Therapeutics

Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s deep expertise in muscle physiology is driving a new generation of first-in-class therapeutics. Sevasemten, previously known as EDG-5506, is an orally administered skeletal myosin inhibitor in clinical trials in patients with Becker, Duchenne, and Limb-Girdle muscular dystrophies as well as McArdle Disease. EDG-7500, currently in a Phase 1 trial, is a novel cardiac sarcomere modulator for the treatment of HCM and other disorders of cardiac diastolic dysfunction. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To learn more, go to: www.edgewisetx.com or follow us on LinkedIn, X (formerly Twitter), Facebook, Instagram and Threads.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240305698537/en/

Edgewise Contacts

Investors:

Michael Carruthers, Chief Financial Officer

ir@edgewisetx.com

Media:

Maureen Franco, VP Corporate Communications

media@edgewisetx.com

Source: Edgewise Therapeutics

FAQ

When will Edgewise Therapeutics (EWTX) present at the Leerink Partners Global Biopharma Conference?

Edgewise Therapeutics will present at the Leerink Partners Global Biopharma Conference on Monday, March 11, 2024.

Where can I find the webcast link for Edgewise Therapeutics' (EWTX) presentation?

The webcast link for Edgewise Therapeutics' presentation can be found on the Edgewise events page.

Will the webcast of Edgewise Therapeutics' (EWTX) presentation be available for replay?

Yes, the webcast of Edgewise Therapeutics' presentation will be accessible for replay following the presentation.

What time will Edgewise Therapeutics' (EWTX) presentation start at the conference?

Edgewise Therapeutics' presentation will start at 12:00 pm ET on March 11, 2024.

Why is it recommended to connect early to the webcast of Edgewise Therapeutics' (EWTX) presentation?

Connecting early to the webcast is recommended to ensure a timely connection and a smooth experience.